BERGSTEIN ADAM D. 4
4 · BioRestorative Therapies, Inc. · Filed Jan 19, 2018
Insider Transaction Report
Form 4
BERGSTEIN ADAM D.
SVP, Planning and Business Dev
Transactions
- Award
Stock Option
2018-01-19+500,000→ 500,000 totalExercise: $3.40Exp: 2028-01-19→ Common Stock (500,000 underlying)
Holdings
- 2
Common Stock
Footnotes (1)
- [F1]The option vests and becomes exercisable on the date on which the initial patient recruitment for the Company's Phase II lumbar clinical trial or comparable product occurs.